Payment overview · 2025
General Payments
$1,100.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Rae Jean Jessee, APRN
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · MAYSVILLE, KY · NPI 1154316065
Verified facts
What the public records show
CMS Open Payments records show Rae Jean Jessee, APRN received $1,100.00 in general payments during 2025 across 1 reported records.
Insulet Corporation accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Insulet Corporation | Unresolved — no canonical attribution shown | $1,100.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,100.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OMNIPOD Normalized: omnipod |
Device | Insulet Corporation | $1,100.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Mounjaro | Tirzepatide | 596 | 76 |
| Levothyroxine Sodium | Levothyroxine Sodium | 442 | 113 |
| Ozempic | Semaglutide | 392 | 75 |
| Tresiba Flextouch U-200 | Insulin Degludec | 279 | 79 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 246 | 62 |
| Metformin Hcl | Metformin Hcl | 226 | 65 |
| Farxiga | Dapagliflozin Propanediol | 213 | 62 |
| Atorvastatin Calcium | Atorvastatin Calcium | 207 | 58 |
| Omeprazole | Omeprazole | 207 | 58 |
| Gabapentin | Gabapentin | 179 | 51 |
| Losartan Potassium | Losartan Potassium | 177 | 49 |
| Lisinopril | Lisinopril | 164 | 47 |
| Pantoprazole Sodium | Pantoprazole Sodium | 161 | 44 |
| Jardiance | Empagliflozin | 154 | 43 |
| Clopidogrel | Clopidogrel Bisulfate | 130 | 32 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 126 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 125 | 35 |
| Furosemide | Furosemide | 124 | 36 |
| Ezetimibe | Ezetimibe | 120 | 28 |
| Novolog Flexpen | Insulin Aspart | 115 | 44 |
| Potassium Chloride | Potassium Chloride | 115 | 34 |
| Glimepiride | Glimepiride | 111 | 30 |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 111 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 108 | 31 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) | Insulin Pump Cart,auto,bt,g6/7 | 107 | 27 |
| Carvedilol | Carvedilol | 102 | 31 |
| Fenofibrate | Fenofibrate | 100 | 21 |
| Amlodipine Besylate | Amlodipine Besylate | 95 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 90 | 30 |
| Trulicity | Dulaglutide | 87 | 22 |
| Metformin Hcl Er | Metformin Hcl | 86 | 27 |
| Humalog Kwikpen U-100 | Insulin Lispro | 85 | 27 |
| Tramadol Hcl | Tramadol Hcl | 84 | 13 |
| Simvastatin | Simvastatin | 78 | 20 |
| Montelukast Sodium | Montelukast Sodium | 76 | 21 |
| Synthroid | Levothyroxine Sodium | 75 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 74 | 22 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 69 | 24 |
| Allopurinol | Allopurinol | 68 | 20 |
| Novolog | Insulin Aspart | 64 | 18 |
| Citalopram Hbr | Citalopram Hydrobromide | 59 | 19 |
| Humulin R U-500 | Insulin Regular, Human | 56 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 54 | 17 |
| Metoprolol Tartrate | Metoprolol Tartrate | 54 | 17 |
| Repatha Sureclick | Evolocumab | 52 | 12 |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 52 | 17 |
| Spironolactone | Spironolactone | 50 | 16 |
| Eliquis | Apixaban | 49 | suppressed |
| Myrbetriq | Mirabegron | 45 | suppressed |
| Fluconazole | Fluconazole | 44 | 26 |
| Ibuprofen | Ibuprofen | 44 | 12 |
| Promethazine Hcl | Promethazine Hcl | 44 | 11 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 43 | 14 |
| Tamsulosin Hcl | Tamsulosin Hcl | 43 | 15 |
| Tizanidine Hcl | Tizanidine Hcl | 43 | 11 |
| Alprazolam | Alprazolam | 41 | 11 |
| Meloxicam | Meloxicam | 40 | 11 |
| Humalog | Insulin Lispro | 39 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 38 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 38 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 36 | 11 |
| Victoza 3-Pak | Liraglutide | 36 | 13 |
| Famotidine | Famotidine | 35 | suppressed |
| Linzess | Linaclotide | 35 | 11 |
| Nystatin | Nystatin | 35 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 34 | 14 |
| Sertraline Hcl | Sertraline Hcl | 34 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 33 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 32 | suppressed |
| Lorazepam | Lorazepam | 32 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 32 | 11 |
| Ondansetron Odt | Ondansetron | 32 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 32 | 12 |
| Liothyronine Sodium | Liothyronine Sodium | 30 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 29 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 29 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 29 | suppressed |
| Korlym | Mifepristone | 29 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 28 | suppressed |
| Glipizide | Glipizide | 28 | suppressed |
| Tradjenta | Linagliptin | 28 | suppressed |
| Insulin Lispro | Insulin Lispro | 27 | suppressed |
| Pregabalin | Pregabalin | 27 | 14 |
| Trazodone Hcl | Trazodone Hcl | 27 | 12 |
| Meclizine Hcl | Meclizine Hcl | 26 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 26 | suppressed |
| Methimazole | Methimazole | 25 | suppressed |
| Azithromycin | Azithromycin | 23 | 19 |
| Gvoke Hypopen 2-Pack | Glucagon | 23 | 11 |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 23 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 22 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 22 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 13 |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 20 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 17 |
| Ultra-Fine Micro Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Xarelto | Rivaroxaban | 20 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 19 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 19 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 19 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 17 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | 13 |
| Temazepam | Temazepam | 17 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Diazepam | Diazepam | 16 | suppressed |
| Humalog Mix 50-50 Kwikpen | Insulin Lispro Protamin/Lispro | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | 12 |
| Armour Thyroid | Thyroid,pork | 15 | suppressed |
| Forteo | Teriparatide | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 15 | suppressed |
| Levemir Flexpen | Insulin Detemir | 15 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 15 | suppressed |
| Finasteride | Finasteride | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Trulance | Plecanatide | 14 | suppressed |
| Cephalexin | Cephalexin | 13 | 12 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | suppressed |
| Clotrimazole | Clotrimazole | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Insulin Syringe | Syring-Needl,disp,insul,0.3 Ml | 12 | suppressed |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 12 | suppressed |
| Methylprednisolone | Methylprednisolone | 12 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 12 | suppressed |
| Tirosint-Sol | Levothyroxine Sodium | 12 | suppressed |
| Humalog Kwikpen U-200 | Insulin Lispro | 11 | suppressed |
| Novolin R | Insulin Regular, Human | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,100.00 · 1 records | Insulet Corporation | OMNIPOD | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error